January 30, 2026

Savara, Inc. (SVRA) Investor Outlook: Analyst Ratings Signal a Potential 93.77% Upside

Savara Inc. (NASDAQ: SVRA), a clinical-stage biopharmaceutical company focused on rare respiratory diseases, has recently caught the attention of investors and analysts alike. With its market cap standing at $1.14..

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: Unlocking a Potential 78.81% Upside in the Biotech Sector

ArriVent BioPharma, Inc. (NASDAQ: AVBP) is emerging as a noteworthy player in the biotechnology sector with a market capitalization of $928.83 million. This clinical-stage biopharmaceutical company is focused on developing..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Navigating Growth with a 7.80% Potential Upside

Phibro Animal Health Corporation (NASDAQ: PAHC), a prominent entity in the healthcare sector, has carved a niche in the drug manufacturing industry, focusing on specialty and generic animal health products...

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: Biotech Visionary with a 205% Potential Upside

As investors search for promising opportunities in the healthcare sector, LENZ Therapeutics, Inc. (NASDAQ: LENZ) emerges as a compelling prospect. Specializing in biopharmaceutical solutions aimed at improving vision, LENZ Therapeutics..

CureVac N.V. (CVAC): Investor Outlook on the German mRNA Innovator Amidst Acquisition by BioNTech

CureVac N.V. (NASDAQ: CVAC), a pioneering biopharmaceutical company based in Tübingen, Germany, has long captured investor interest with its focus on messenger ribonucleic acid (mRNA) technology. With a market capitalization..

Cronos Group Inc. (CRON) Stock Analysis: Navigating a 6.1% Revenue Growth in a Challenging Market

Cronos Group Inc. (CRON), a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, stands at an intriguing crossroad for investors. With a market..

Zymeworks Inc. (ZYME): Investor Outlook on a Promising Biotech with 59% Upside Potential

Zymeworks Inc. (NASDAQ: ZYME), a clinical-stage biotechnology company, is making waves in the healthcare sector with its innovative approach to developing biotherapeutics for cancer and autoimmune diseases. With a market..

InMode Ltd. (INMD) Stock Analysis: A Look at Financial Health and Market Positioning

For investors eyeing the dynamic field of minimally invasive medical aesthetics, InMode Ltd. (NASDAQ: INMD) presents a compelling opportunity. Based in Yokne’am, Israel, this healthcare sector player operates within the..

CareDx, Inc. (CDNA) Stock Analysis: Exploring Growth Potential with a 5.77% Upside

CareDx, Inc. (NASDAQ: CDNA), a prominent player in the healthcare sector specializing in diagnostics and research, is gaining significant attention from investors. With a market capitalization of $1.11 billion, CareDx..

Ilika moves into commercial phase with first Stereax electrode order

Ilika has received its first commercial order for Stereax battery electrodes, marking the start of scaled production for medical device applications...

KEFI finalises senior loan deal to launch Tulu Kapi gold project

KEFI secures final loan signing to unlock full development of its Ethiopian gold project...

IG Group completes acquisition of Independent Reserve

IG Group Holdings plc has completed its acquisition of crypto exchange Independent Reserve following regulatory approval from the Monetary Authority of Singapore...

ICG Enterprise Trust reports 2.4% Q3 NAV total return, raises FY26 dividend guidance

ICG Enterprise Trust plc delivered a 2.4% NAV per share total return for the three months to 31 October 2025, supported by £82m of realisations and disciplined investment activity...

AstraZeneca signs $1.2bn obesity drug collaboration with CSPC

Under a new agreement with CSPC Pharmaceuticals, AstraZeneca will advance eight programmes targeting obesity and weight-related conditions, initially progressing four assets through Phase I...

Thor Energy advances clean energy and strategic metals portfolio

During the October–December 2025 quarter, Thor Energy advanced its HY-Range natural hydrogen and helium project toward drill readiness, completed key non-dilutive asset monetisations, and reinforced its exposure to South Australian..

Drax signs 250MW battery storage tolling agreement with Fidra Energy

Drax has entered into a 10-year tolling agreement with Fidra Energy for a 250MW (500MWh) battery energy storage system at West Burton in England...

Great Western Mining raises £3.25m to advance Nevada tungsten project

Great Western Mining Corporation has raised £3.25 million before expenses through an oversubscribed placing at 1.4p per share...

Likewise Group £163.8m Revenue and No Signs of Slowing in UK Flooring Market (Video)

Likewise Group CEO Tony Brewer explains how the company achieved 8.6% revenue growth in a down market — and why its infrastructure investments signal ambitions well beyond £250m...

XPS Pensions Group PLC (XPS.L): Analyst Consensus Signals a 29% Upside Potential for Investors

XPS Pensions Group PLC, listed on the stock exchange under the ticker XPS.L, is making waves in the investment community with its robust growth prospects and a compelling analyst outlook...

Vesuvius PLC (VSVS.L) Stock Analysis: Why This UK Steel Giant Offers a 5.06% Dividend Yield with a 2.59% Potential Upside

Vesuvius PLC (VSVS.L), a stalwart in the Basic Materials sector and a key player in the steel industry, has been attracting investor attention with its robust dividend yield and potential..

Search

Funds

January 30, 2026

Ilika moves into commercial phase with first Stereax electrode order

Ilika has received its first commercial order for Stereax battery electrodes, marking the start of scaled production for medical device applications...

KEFI finalises senior loan deal to launch Tulu Kapi gold project

KEFI secures final loan signing to unlock full development of its Ethiopian gold project...

IG Group completes acquisition of Independent Reserve

IG Group Holdings plc has completed its acquisition of crypto exchange Independent Reserve following regulatory approval from the Monetary Authority of Singapore...

ICG Enterprise Trust reports 2.4% Q3 NAV total return, raises FY26 dividend guidance

ICG Enterprise Trust plc delivered a 2.4% NAV per share total return for the three months to 31 October 2025, supported by £82m of realisations and disciplined investment activity...

AstraZeneca signs $1.2bn obesity drug collaboration with CSPC

Under a new agreement with CSPC Pharmaceuticals, AstraZeneca will advance eight programmes targeting obesity and weight-related conditions, initially progressing four assets through Phase I...

Thor Energy advances clean energy and strategic metals portfolio

During the October–December 2025 quarter, Thor Energy advanced its HY-Range natural hydrogen and helium project toward drill readiness, completed key non-dilutive asset monetisations, and reinforced its exposure to South Australian copper-gold assets...

Drax signs 250MW battery storage tolling agreement with Fidra Energy

Drax has entered into a 10-year tolling agreement with Fidra Energy for a 250MW (500MWh) battery energy storage system at West Burton in England...

Great Western Mining raises £3.25m to advance Nevada tungsten project

Great Western Mining Corporation has raised £3.25 million before expenses through an oversubscribed placing at 1.4p per share...

Likewise Group £163.8m Revenue and No Signs of Slowing in UK Flooring Market (Video)

Likewise Group CEO Tony Brewer explains how the company achieved 8.6% revenue growth in a down market — and why its infrastructure investments signal ambitions well beyond £250m...
Search

Funds

January 30, 2026

FTSE 100

Funds